Decadron Ocumeter Side Effects
Generic name: dexamethasone ophthalmic
Medically reviewed by Drugs.com. Last updated on Jun 1, 2024.
Note: This document provides detailed information about Decadron Ocumeter.
For healthcare professionals
Applies to dexamethasone ophthalmic: intraocular implant, intraocular suspension, ophthalmic insert, ophthalmic ointment, ophthalmic solution, ophthalmic suspension Side Effects associated with dexamethasone ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Decadron Ocumeter.
For healthcare professionals
Applies to dexamethasone ophthalmic: intraocular implant, intraocular suspension, ophthalmic insert, ophthalmic ointment, ophthalmic solution, ophthalmic suspension.
General adverse events
The most commonly reported side effects were cataract, elevation of intraocular pressure, and conjunctival hemorrhage.[Ref]
Ocular
- Very common (10% or more): Cataract (up to 68%), elevation of intraocular pressure (28%), conjunctival hemorrhage (22%)
- Common (1% to 10%): Eye pain, conjunctival hyperemia, ocular hypertension, reduced visual acuity, conjunctivitis, vitreous floaters, conjunctival edema, dry eye, vitreous detachment, vitreous opacities, retinal aneurysm, foreign body sensation, corneal erosion, keratitis, anterior chamber inflammation, retinal tear, eyelid ptosis, vitreous detachment, keratoconjunctivitis sicca, corneal staining, photophobia, blurred vision, eye pruritus, increased lacrimation
- Rare (less than 0.1%): Burning, stinging
- Frequency not reported: Glaucoma with optic nerve damage, visual acuity and visual field defects, subcapsular cataract formation, secondary ocular infection and perforation of the globe
Postmarketing experience: Complication of device insertion (implant misplacement), device dislocation with or without corneal edema, endophthalmitis, hypotony of the eye (associated with vitreous leakage due to injection), retinal detachment[Ref]
Cardiovascular
- Very common (10% or more): Hypertension (13%)[Ref]
Nervous system
- Common (1% to 10%): Headache
- Uncommon (0.1% to 1%): Dysgeusia, migraine
- Frequency not reported: Dizziness[Ref]
Respiratory
- Common (1% to 10%): Bronchitis[Ref]
Endocrine
- Postmarketing reports: Cushing's syndrome, adrenal suppression
Cushing's syndrome and adrenal suppression may occur at doses higher than recommended in predisposed patients including children and those on CYP P450 3A4 inhibitors.
References
1. (2001) "Product Information. Decadron Ocumeter (dexamethasone ophthalmic)." Merck & Co., Inc
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
4. (2009) "Product Information. Ozurdex (dexamethasone ophthalmic)." Allergan Inc
More about Decadron Ocumeter (dexamethasone ophthalmic)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids
- Breastfeeding
Patient resources
Other brands
Ozurdex, Maxidex, Dextenza, Dexycu, Ocu-Dex
Professional resources
Other brands
Ozurdex, Maxidex, Dextenza, Dexycu
Related treatment guides
Further information
Decadron Ocumeter side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.